MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Author MStranslate

MStranslate

Dr Travis Stiles

Dr Travis Stiles Officially Joins MStranslate

MStranslate
October 13, 2021
Collaboration, Community, Dr Travis Stiles
1 Comment
Many in our community will recognise Dr Travis Stiles (CEO, Novoron Bioscience), as he has been a regular guest contributor to MStranslate since 2016.  Now, we can excitedly share that Travis is joining the...
Multiple Sclerosis Cure

Community Q&A: Why Don’t We Have An MS Cure?

MStranslate
October 11, 2021
Community, Opinion, Q&A
In this video, our co-founder and chief science communicator, Brett Drummond, answers one of the recent questions submitted by a member of the MStranslate community. In this instance, he shares his opinions on...
COVID-19 vaccines

Community Q&A: COVID-19 Vaccines & MS

MStranslate
September 29, 2021
Community, COVID-19, Q&A, Research
1 Comment
In this video, our co-founder and chief science communicator, Brett Drummond, answers one of the recent questions submitted by a member of the MStranslate community. In this instance, it looks at the latest...
blood-brain barrier

Community Q&A: The Blood-Brain Barrier

MStranslate
September 23, 2021
Community, Q&A, Research
2 Comments
What is the blood-brain barrier? Why is the blood-brain barrier important in multiple sclerosis (MS)?  Is research being undertaken to repair the blood-brain barrier in people living with multiple sclerosis,...
cure

UPDATED: Redefining A “Cure” For Multiple Sclerosis

MStranslate
September 14, 2021
Opinion
5 Comments
UPDATED: SEPTEMBER 14, 2021 https://youtu.be/02TR0rhHGUc ORIGINAL ARTICLE: JUNE 19, 2018 The following is an opinion piece written by MStranslate co-founder, Brett Drummond.  As always, we value your...
lockdown fatigue

Not MS Fatigue, but Lockdown Fatigue: Dr Sally Shaw

MStranslate
August 13, 2021
COVID-19, Dr Sally Shaw, Infection, Mental Health, Symptoms
By Dr Sally Shaw. Lockdown is a strange beast isn’t it?  Whether you are flat out on Zoom, or staring at the ceiling between Netflix episodes, most people are reporting high levels of ‘over it’ and...
Constipation multiple sclerosis

Constipation & Multiple Sclerosis: Study Insights

MStranslate
August 5, 2021
Gut microbiome, Research
The gut microbiome is an area of significant interest in multiple sclerosis (MS) research. Studies have shown that people living with MS have different levels of diversity in their gut microbiome compared to...
fatigue

Treating Fatigue in Multiple Sclerosis

MStranslate
July 20, 2021
Fatigue, Research, Symptoms, Treatments
Fatigue.  It is one of the most commonly reported symptoms by people living with multiple sclerosis (MS).  Not only do many people experience it, but they also indicate that it is the symptom that has the...
AstraZeneca Vaccine

Safety of AstraZeneca COVID-19 Vaccine in PwMS

MStranslate
June 7, 2021
COVID-19, Infection, Research, Treatments
2 Comments
One of the most common questions that I have received from the MStranslate community lately is whether there is any new information about the COVID vaccines for people living with multiple sclerosis. Last...
fake news

FAKE NEWS ALERT: COVID Vaccines & MS

MStranslate
June 2, 2021
Research, Understanding Science
4 Comments
If you have been following MStranslate for a while, you will know that one of my pet hates is the poor reporting of multiple sclerosis research online (especially when it's fake news).  In fact, it is one of...
  1. 2
  2. 3
  3. 4
  4. 5
  5. 6
  6. 7
  7. 8

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.